Company Filing History:
10 out of 3,381 
1 out of 3,539 
1 out of 484 
Years Active: 2008-2014
Title: Innovations and Contributions of Inventor Haiying Sun
Introduction
Haiying Sun is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic methods targeting Inhibitor of Apoptosis Proteins (IAPs). With a total of 11 patents to his name, his work has the potential to impact the treatment of various diseases, including cancer.
Latest Patents
Haiying Sun's latest patents include innovative approaches to inhibiting IAP proteins. One of his notable inventions is the "Bivalent inhibitors of IAP proteins and therapeutic methods using the same." This patent discloses inhibitors of IAP proteins and methods for using these inhibitors in treating diseases where IAP protein inhibition is beneficial, such as cancers. Another significant patent is for "Bivalent diazo bicyclic Smac mimetics and the uses thereof." This invention relates to diazo bicyclic Smac mimetics that are tethered through a covalent linker, functioning as inhibitors of IAPs. These compounds are useful in inducing or sensitizing cells to apoptotic cell death, making them valuable in the treatment of hyperproliferative diseases like cancer.
Career Highlights
Throughout his career, Haiying Sun has worked with esteemed institutions such as the University of Michigan and the National Institutes of Health, a component of the US Department of Health & Human Services. His research has focused on developing novel therapeutic strategies that leverage the mechanisms of apoptosis to combat cancer and other diseases.
Collaborations
Haiying Sun has collaborated with notable colleagues, including Shaomeng Wang and Zaneta Nikolovska-Coleska. Their combined expertise has contributed to advancing research in the field of cancer therapeutics.
Conclusion
Haiying Sun's innovative work and numerous patents reflect his dedication to improving therapeutic options for patients suffering from cancer and other diseases. His contributions to the field of biomedical research continue to pave the way for future advancements in treatment methodologies.